BRAIDO, FULVIO
 Distribuzione geografica
Continente #
EU - Europa 22.610
AS - Asia 2.350
NA - Nord America 977
SA - Sud America 182
AF - Africa 53
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 26.178
Nazione #
IT - Italia 22.106
SG - Singapore 1.071
US - Stati Uniti d'America 913
CN - Cina 592
VN - Vietnam 387
FR - Francia 196
BR - Brasile 113
HK - Hong Kong 101
FI - Finlandia 80
DE - Germania 66
NL - Olanda 57
AR - Argentina 33
JP - Giappone 33
MX - Messico 29
IQ - Iraq 24
ID - Indonesia 22
ES - Italia 21
BD - Bangladesh 17
CH - Svizzera 17
IN - India 17
GB - Regno Unito 16
CA - Canada 13
PH - Filippine 11
IE - Irlanda 10
KE - Kenya 9
MA - Marocco 9
CO - Colombia 8
SA - Arabia Saudita 8
NP - Nepal 7
PY - Paraguay 7
RU - Federazione Russa 7
ZA - Sudafrica 7
AT - Austria 6
EC - Ecuador 6
TR - Turchia 6
UZ - Uzbekistan 6
AU - Australia 5
PK - Pakistan 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
HN - Honduras 4
SE - Svezia 4
UA - Ucraina 4
VE - Venezuela 4
AZ - Azerbaigian 3
CL - Cile 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
HR - Croazia 3
JO - Giordania 3
KG - Kirghizistan 3
KR - Corea 3
KZ - Kazakistan 3
LB - Libano 3
MY - Malesia 3
OM - Oman 3
PE - Perù 3
SN - Senegal 3
TW - Taiwan 3
UY - Uruguay 3
BE - Belgio 2
BJ - Benin 2
BO - Bolivia 2
CD - Congo 2
GT - Guatemala 2
IL - Israele 2
MU - Mauritius 2
NG - Nigeria 2
PA - Panama 2
PL - Polonia 2
TN - Tunisia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GA - Gabon 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
NA - Namibia 1
NE - Niger 1
NI - Nicaragua 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
Totale 26.171
Città #
Genova 13.147
Genoa 5.469
Rapallo 1.871
Vado Ligure 1.422
Singapore 517
San Jose 338
Lauterbourg 183
Ashburn 143
Council Bluffs 121
Ho Chi Minh City 112
Hong Kong 97
Hanoi 89
Helsinki 72
Bordighera 63
New York 62
Beijing 57
Frankfurt am Main 47
Amsterdam 42
Santa Clara 34
Tokyo 30
Da Nang 19
Mexico City 17
Haiphong 16
Milan 16
Tianjin 15
Zurich 15
Biên Hòa 11
Los Angeles 11
Baghdad 10
Dublin 10
Chicago 9
Shanghai 9
Can Tho 8
City of London 8
Dallas 8
Lappeenranta 8
Orem 8
Santiago de Compostela 8
Bologna 7
Guangzhou 7
Jakarta 7
Naples 7
Berlin 6
Hải Dương 6
Nairobi 6
Rome 6
Tashkent 6
Atlanta 5
Nuremberg 5
São Paulo 5
Belo Horizonte 4
Buffalo 4
Bắc Giang 4
Bắc Ninh 4
Cao Lanh 4
Cardiff 4
Ciudad del Este 4
Des Moines 4
Jeddah 4
Madrid 4
Malang 4
Montreal 4
Ninh Bình 4
Paris 4
Rio de Janeiro 4
Shenzhen 4
Toronto 4
Trieste 4
Baku 3
Bangkok 3
Curitiba 3
Dakar 3
Dammam 3
Dhaka 3
Guayaquil 3
Hyderabad 3
Johannesburg 3
Makati City 3
Montevideo 3
Muscat 3
Ourinhos 3
Port of Spain 3
Porto Alegre 3
Rabat 3
Recife 3
Seattle 3
Tampa 3
Turin 3
Vienna 3
Amman 2
Asunción 2
Betim 2
Brescia 2
Brussels 2
Buenos Aires 2
Camden 2
Charlotte 2
Chennai 2
Detroit 2
Duhok 2
Totale 24.352
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 321
RAPP-children: A new tool for assessing quality of life in patients with asthma and rhinitis 268
Administration of a polyvalent mechanical bacterial lysate to elderly patients with COPD: Effects on circulating T, B and NK cells. 205
The perception of Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) among Italian general practitioners 202
null 200
Patients beliefs on intravenous and subcutaneous routes of administration of biologics for severe asthma treatment: A cross-sectional observational survey study 198
'Emergency exit' of bone-marrow-resident CD34+ DNAM-1 bright CXCR4+-committed lymphoid precursors during chronic infection and inflammation 196
Exploring the Relationship between Disease Awareness and Outcomes in Patients with Chronic Obstructive Pulmonary Disease 192
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 188
A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire. 186
"Trying, But Failing" - The Role of Inhaler Technique and Mode of Delivery in Respiratory Medication Adherence 178
The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes 177
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial 177
Antiallergic drugs and quality of life. 176
Genuair® Usability Test: Results of a National Public Survey of the Elderly 173
Sleep complaints and sleep breathing disorders in upper and lower obstructive lung diseases 173
COPD treatment: Real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion. 172
A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). 170
Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice 170
An update on allergen immunotherapy and asthma 169
Allergic diseases and their impact on quality of life. 168
CD4+CD25highCD127- regulatory T-cells in COPD: Smoke and drugs effect 168
Clara cell 16 protein in COPD sputum: A marker of small airways damage? 167
Basi Patogenetiche ed anatomopatologiche della flogosi allergica nell’asma bronchiale 166
Why use long acting bronchodilators in chronic obstructive lung diseases? An extensive review on formoterol and salmeterol 164
Allergic rhinitis and asthma ad hoc survey: clinical and psychological perspectives. 163
Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study 163
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 163
The Portuguese version of Rhinitis and Asthma Patient's Perspective (RAPP): Validation and assessment 163
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. 161
The relationship between allergen immunotherapy and omalizumab for treating asthma 160
Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD spirometric classification: A multicentre, double-blind, randomised, controlled, phase IV study (AIACE study: Advanced Immunological Approach in COPD Exacerbation) 160
Umeclidinium for the treatment of uncontrolled asthma 160
Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases? 160
RhinAsthma patient perspective: A Rasch validation study 159
Patient-physician relationship in the management of asthma: Multicentric approach in Latin America 159
Adherence to treatment: assessment of an unmet need in asthma. 158
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN) 158
Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. 158
Pidotimod: The state of art 157
The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context 157
Biosimilars in allergic diseases 157
Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study 156
The ARGA study with general practitioners: Impact of medical education on asthma/rhinitis management 154
Adherence to asthma treatments: 'We know, we intend, we advocate' 153
Disease awareness in patients with COPD: measurement and extent 153
Diurnal mouthpiece ventilation and nocturnal non-invasive ventilation versus tracheostomy invasive ventilation in patients with amyotrophic lateral sclerosis. 152
InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients--the LIAISON study protocol. 150
Minimal clinical important difference (MCID) of the Thai chronic urticaria quality of life questionnaire (CU-Q2oL) 150
Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users 150
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 149
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. 149
Illness perception, mood and coping strategies in allergic rhinitis: are there differences among ARIA classes of severity? 148
Randomized controlled trials and real life studies. Approaches and methodologies: A clinical point of view 148
Disability in moderate chronic obstructive pulmonary disease: Prevalence, burden and assessment-results from a real-life study 148
Minimal important difference of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) 148
Coping with asthma: is the physician able to identify patient's behaviour? 147
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 146
New therapies for allergic rhinitis 145
Cost-description and multiple imputation of missing values: the SATisfaction and adherence to COPD treatment (SAT) study 145
A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management 145
RHINASTHMA-Adolescents: a new quality of life tool for patients with respiratory allergy 144
Why do doctors and patients not follow guidelines? 143
Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. 143
Quality-of-life issues in survivors to anaphylactic reactions to drugs 143
Patient-reported outcomes in asthma clinical trials 143
Non-invasive ventilation in acute respiratory failure of patients with obesity hypoventilation syndrome 143
Impact of asthma and comorbid allergic rhinitis on quality of life and control in patients of italian general practitioners 143
Long-acting bronchodilators improve health related quality of life in patients with COPD. 142
Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. 141
Pitfalls in respiratory allergy management: alexithymia and its impact on patient-reported outcomes. 141
New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide. 141
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 141
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation 140
Effects of mometasone furoate on the quality of life: a randomized placebo-controlled trial in persistent allergic rhinitis and intermittent asthma using the Rhinasthma questionnaire. 139
Asthma treatment: 'magic bullets which seek their own targets'. 138
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 138
The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review. 138
Does asthma control correlate with quality of life related to upper and lower airways? A real life study. 137
From "blockbusters" to "biosimilars": An opportunity for patients, medical specialists and health care providers 137
Asthma management failure: a flaw in physicians' behavior or in patients' knowledge? 137
Does a low-density gas mixture or oxygen supplementation improve exercise training in COPD? 136
Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. 135
Continuing Medical Education:an international reality 135
Phenotypes/endotypes-driven treatment in asthma 134
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 134
“ Immunologia dell’apparato Respiratorio e metodiche di studio “ Cap 8 132
Sleep disturbances in allergic diseases. 132
Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. 132
ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. 132
Aqua©: Allergy questionnaire for athletes. Development and validation 132
Quality of life in Duchenne muscular dystrophy: the subjective impact on children and parents. 132
Worldwide differences on the concept of control of asthma. 131
Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR) 131
Development and validation of the Drug Hypersensitivity Quality of Life Questionnaire. 130
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement 130
Transoral glossoepiglottopexy in the treatment of adult obstructive sleep apnoea: A surgical approach [Glossoepiglottoplastica con approccio trans-orale nel trattamento delle apnee ostruttive notturne nell’adulto] 129
Rhinitis: Adherence to treatment and new technologies 128
The anti-inflammatory properties of tiotropium 128
Allergic rhinitis in asthma. 128
Totale 15.589
Categoria #
all - tutte 85.857
article - articoli 85.067
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 790
Totale 171.714


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021513 0 0 0 0 0 0 0 0 0 200 150 163
2021/20222.437 127 164 117 243 52 250 119 570 182 213 106 294
2022/20232.276 249 118 21 236 326 413 52 181 395 55 184 46
2023/20241.097 61 161 24 115 98 167 90 79 57 28 96 121
2024/20253.448 45 264 131 223 486 375 328 486 184 213 343 370
2025/20266.319 735 195 838 441 828 695 1.128 321 512 626 0 0
Totale 26.878